Summary
Twenty patients with well controlled Type 1 (insulin-dependent) diabetes of at least 10 years duration and 47 control subjects were vaccinated against the hepatitis B virus using the Hevac B vaccine. The vaccine was administered into the deltoid region on three occasions at intervals of 1 month. Thereafter a fourth dose was given to subjects still negative for antibody to hepatitis B surface antigen (HbsAb). The median rise of HbsAb titres was 230 mIU/ml in normal subjects and 50 mIU/ml in diabetic patients (p<0.001). Eight patients (40%) failed to reach HbsAb titres above 30 mIU/ml, the level considered to give optimal protection against the infection, whereas only one normal control subject failed to reach this level. Five patients (25%) showed no response despite a fourth dose of the vaccine. There was an increased frequency of HLA-DR7 in low responders and a decreased (<1.5) helper/suppressor lymphocyte ratio. Diabetic patients are thus less likely to mount a protective antibody response following vaccination against hepatitis. Since hepatitis B surface antigen is reported to be considerably more common in diabetic patients than control subjects, infection with hepatitis B virus may have a greater risk of chronicity in diabetes.
Article PDF
Similar content being viewed by others
References
Drell DW, Notkins AL (1987) Multiple immunological abnormalities in patients with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 132–143
Pozzilli P, Zuccarini O, Tavicoli M, Andreani D, Sensi M, Spencer KM, Bottazzo GF, Beverley PCL, Kyner JL, Cudworth AG (1983) Monoclonal antibodies define abnormalities of T lymphocyte subsets in diabetes. Diabetes 32: 91–94
Herold KC, Huen H, Gould L, Traisman H, Rubenstein AH (1984) Alterations in lymphocyte subpopulations in Type 1 (insulin-dependent) diabetes mellitus: exploration of possible mechanisms and relationships to autoimmune phenomena. Diabetologia 27: 102–105
Pozzilli P, Negri M, Visalli N, Pagani S, Beales P, Andreani D (1986) Impaired CD4/CD8 lymphocyte ratio in patients with long-standing diabetes mellitus. IRCS Med Sci 14: 648–649
Bagdade JD, Nielson KL, Bulger RJ (1972) Reversible abnormalities in phagocytic function in poorly controlled diabetic patients. Am J Med Sci 263: 451–456
McCuish AC, Jordan J, Campbell CJ, Duncan LJP, Irvine WJ (1974) Phytohaemagglutinin lymphocyte transformation and circulating lymphocyte subpopulations in insulin-dependent diabetes. Diabetes 23: 708–712
Robertson HD, Polk HC (1974) The mechanisms of infections in patients with diabetes mellitus: a review of leucocyte malfunction. Surgery 785: 123–128
Pozzilli P, Gale EAM, Visalli N, Baroni M, Crovari P, Frighi V, Cavallo MG, Andreni D (1986) The immune response to influenza vaccination in diabetic patients. Diabetologia 29: 850–854
Diepersloot RJA, Bouter KP, Beyer WE, Hoekstra JBL, Masurel N (1987) Humoral immune response and delayed type hypersensitivity to influenza vaccine in patients with diabetes mellitus. Diabetologia 30: 397–401
Pozzilli P, Pagani SD, Arduini P, Visalli N, Cioccia GP, Negri M, Andreani D (1987) In-vivo determination of cell mediated immunity in diabetic patients using a new intradermal antigen dispenser. Diabetes Res 6 (in press)
Madalinski K, Brzosko W, Malezewski M, Czyzyk A (1971) Australia Antigen in sera of diabetic patients. Lancet I: 701–702
Muller R (1969) Frequency of liver disease in diabetes mellitus. Acta Diabetol Lat 6: 614–622
Alter HJ (1982) The evolution, implications and applications of the Hepatitis B vaccine. JAMA 247: 2272
Walker M, Szmuness W, Stevens C, Rubinstein P (1981) Genetics of anti-HBs responsiveness HLA-DR7 and non-responsiveness to Hepatitis vaccination. Proceedings American Association of Blood Banks, 34th Annual Meeting (Abstracts 21) 5: 601
Pead PJ (1986) Immune responses to Hepatitis B vaccination in hospital staff. Biomed Pharmacother 40: 251–253
Reinherz EL, Rubinstein A, Geha RS, Strelkauskas AJ, Rosen FS, Schlossman SF (1979) Abnormalities of immunoregulatory T-cells in disorders of the immune function. N Engl J Med 301: 1018–1022
Beverley PCL, O'Flynn P, Wallace D, Lamb JR, Boylston AW, Linch DC (1986) Regulation of activation and proliferation in T-cells. In: Reinherz FL, Haynes BF, Nadler LM, Bernstein ID (eds) Leucocyte Typing II, Regulation of activation and proliferation in T-cells. Vol 1. Springer, Berlin Heidelberg New York Tokyo, pp 427–439
Rayfield EJ, Ault MJ, Keush GT, Brothers MJ, Nechemias C, Smith H (1982) Infections and diabetes: the case for glucose control. Am J Med 72: 439–450
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pozzilli, P., Arduini, P., Visalli, N. et al. Reduced protection against hepatitis B virus following vaccination in patients with Type 1 (insulin-dependent) diabetes. Diabetologia 30, 817–819 (1987). https://doi.org/10.1007/BF00275749
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00275749